Effects of stopping aspirin in older adults with Alzheimer's and related dementias
Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias
This study is looking at what happens when older adults with Alzheimer's Disease and related dementias stop taking low-dose aspirin, which is usually taken to help prevent heart problems, to help figure out the best choice for their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11015803 on NIH RePORTER |
What this research studies
This research investigates the health outcomes of discontinuing low-dose aspirin in older adults who have Alzheimer's Disease and Related Dementias (ADRD). It aims to understand the risks and benefits of stopping aspirin, which is often used for heart disease prevention, in this specific population. The study will gather real-world data to help inform decisions about whether older adults with ADRD should continue or stop taking aspirin, considering their unique health needs. By examining the potential impacts on both cardiovascular health and cognitive function, the research seeks to provide clearer guidance for patients, caregivers, and healthcare providers.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who have been diagnosed with Alzheimer's Disease or related dementias and are currently taking low-dose aspirin.
Not a fit: Patients who are younger than 65 or do not have Alzheimer's Disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed decisions regarding aspirin use in older adults with Alzheimer's and related dementias, potentially improving their overall health outcomes.
How similar studies have performed: While there is limited data on aspirin use specifically in older adults with ADRD, similar studies in other populations have shown varying outcomes, indicating that this research could provide novel insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Thorpe, Carolyn Timberlake — Univ of North Carolina Chapel Hill
- Study coordinator: Thorpe, Carolyn Timberlake
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.